Clinical Trial

Role of Lactoferrin in Prevention of Ventilator Associated Pneumonia in Neonates.

Completed
View on ClinicalTrials.gov →
Summary
The aim of the study is to 1. Evaluate the preventive value of Lactoferrin on VAP among ventilated neonates. 2. Evaluate the Primary outcome of Lactoferrin on: Sepsis, Feeding intolerance, Vomiting, Constipation or diarrhea 3. Evaluate the effect of Lactoferrin in critically ventilated neonates on: Incidence of VAP Duration of mechanical ventilation Duration of hospital stay
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-20.
Status change: Active, Not Recruiting → Completed 2026-01-29
Trial Details
NCT Number NCT07255742
Lead Sponsor Dalia Mohamed Salah
Conditions Ventilator Associated Pneumonia
Enrollment 50 participants
Start Date 2025-08-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2025-12-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-02